A detailed history of Sg Americas Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,264,378 shares of BMY stock, worth $61.6 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,264,378
Previous 2,931,743 56.87%
Holding current value
$61.6 Million
Previous $159 Million 66.97%
% of portfolio
0.31%
Previous 0.76%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $67.1 Million - $88.4 Million
-1,667,365 Reduced 56.87%
1,264,378 $52.5 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $48.6 Million - $55.1 Million
1,013,267 Added 52.82%
2,931,743 $159 Million
Q4 2023

Jan 12, 2024

BUY
$48.48 - $57.85 $80.8 Million - $96.4 Million
1,666,229 Added 660.55%
1,918,476 $98.4 Million
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $34.1 Million - $38.1 Million
-588,473 Reduced 70.0%
252,247 $14.6 Million
Q2 2023

Jul 10, 2023

BUY
$63.71 - $70.74 $21.7 Million - $24.1 Million
340,741 Added 68.15%
840,720 $53.8 Million
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $9.35 Million - $10.6 Million
142,358 Added 39.81%
499,979 $34.7 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $4.83 Million - $5.71 Million
-70,469 Reduced 16.46%
357,621 $25.7 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $14,105 - $8.34 Million
108,506 Added 33.95%
428,090 $30.4 Million
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $22.5 Million - $24.8 Million
309,457 Added 3055.76%
319,584 $24.6 Million
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $11.6 Million - $13.9 Million
-188,583 Reduced 94.9%
10,127 $740,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $5.17 Million - $6.03 Million
96,392 Added 94.21%
198,710 $12.4 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $1.14 Million - $1.33 Million
19,188 Added 23.08%
102,318 $6.05 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $2.36 Million - $2.58 Million
-38,198 Reduced 31.48%
83,130 $5.56 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $2.2 Million - $2.48 Million
-37,109 Reduced 23.42%
121,328 $7.66 Million
Q4 2020

Feb 04, 2021

SELL
$57.74 - $65.43 $16.4 Million - $18.6 Million
-284,138 Reduced 64.2%
158,437 $9.83 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $7.14 Million - $7.91 Million
124,314 Added 39.06%
442,575 $26.7 Million
Q2 2020

Jul 20, 2020

BUY
$54.82 - $64.09 $6.03 Million - $7.06 Million
110,082 Added 52.88%
318,261 $18.7 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $32.1 Million - $46.7 Million
-691,960 Reduced 76.87%
208,179 $11.6 Million
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $44 Million - $57.3 Million
893,149 Added 12777.53%
900,139 $57.8 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $24.5 Million - $29.1 Million
-573,411 Reduced 98.8%
6,990 $354,000
Q2 2019

Jul 29, 2019

BUY
$44.62 - $49.34 $9.98 Million - $11 Million
223,555 Added 62.65%
580,401 $26.3 Million
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $6.38 Million - $7.61 Million
-141,423 Reduced 28.38%
356,846 $17 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $3.5 Million - $4.54 Million
-71,857 Reduced 12.6%
498,269 $25.9 Million
Q3 2018

Nov 06, 2018

BUY
$55.19 - $62.25 $15.5 Million - $17.4 Million
279,989 Added 96.5%
570,126 $35.4 Million
Q2 2018

Aug 07, 2018

BUY
$50.53 - $62.98 $1.19 Million - $1.48 Million
23,572 Added 8.84%
290,137 $16.1 Million
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $7.81 Million - $8.99 Million
-130,385 Reduced 32.85%
266,565 $16.9 Million
Q4 2017

Jan 24, 2018

BUY
$59.94 - $65.35 $7.32 Million - $7.98 Million
122,175 Added 44.46%
396,950 $24.3 Million
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $15.2 Million - $17.5 Million
274,775
274,775 $17.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.